DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured with numerous awards in the second half of 2024. On TIME Magazine's 2024 list of World's Best Companies ICON was ranked as the highest clinical research organisation out of 1,000 companies for the second year in a row, and in its 2025 list of World's Be...
Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain strong and structural growth drivers are still intact. Short-term headwinds led to attractive valuations, offering a compelling investment opportunity.
LOS ANGELES , Dec. 5, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company ("Icon" or the "Company") (NASDAQ: ICLR) on behalf of investors concerning the Company's possible violations of federal securities laws.
DUBLIN--(BUSINESS WIRE)--ICON announces results from a global survey of biopharma professionals on AI and digital innovation adoption within clinical research.
BENSALEM, Pa., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company's possible violations of federal securities laws.
LOS ANGELES, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR ) on behalf of investors concerning the Company's possible violations of federal securities laws.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.